Literature DB >> 21853518

Determination of deferiprone in urine and serum using a terbium-sensitized luminescence method.

Jamshid L Manzoori1, Mohammad Amjadi, Jafar Soleymani, Elnaz Tamizi, Azim Rezamand, Abolghasem Jouyban.   

Abstract

Optimized conditions, validation and practical applications of a new, rapid and specific fluorometric method for the determination of deferiprone (DFP) in urine and serum samples are reported. The proposed method, which is based on the formation of a luminescent complex with Tb(3+) ion, is evaluated in terms of linearity, accuracy, precision, stability, recovery and limits of detection (LOD) and quantification (LOQ). Under optimum conditions (pH 7.5, [Tb(3+)] = 3 × 10(-4)  mol/L, temperature 0 °C and excitation wavelength 295 nm), the relative intensities at 545 nm are linear, with the concentration of DFP in the range 0.072-13 mmol/L for urine and serum samples. The LOD and LOQ, respectively, are calculated to be 0.014 and 0.045 mmol/L for urine and 0.022 and 0.072 mmol/L for serum samples. The intra-day and inter-day values for the precision and accuracy of the proposed method are all < 5%, and the recovery of the method is in the range 97.1-103.8%. The method was applied to human urine and serum samples collected from patients receiving DFP. The results indicated that the method can be successfully applied to the determination of DFP in human urine and serum samples collected for clinical or biopharmaceutical investigations in which simple, rapid, cheap and specific determination methods facilitate and speed up the analytical procedure.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21853518     DOI: 10.1002/bio.1344

Source DB:  PubMed          Journal:  Luminescence        ISSN: 1522-7235            Impact factor:   2.464


  4 in total

1.  A ratiometric fluorometric and colorimetric probe for the β-thalassemia drug deferiprone based on the use of gold nanoclusters and carbon dots.

Authors:  Yanying Wang; Lei Mao; Wei Liu; Fang Ding; Ping Zou; Xianxiang Wang; Qingbiao Zhao; Hanbing Rao
Journal:  Mikrochim Acta       Date:  2018-09-01       Impact factor: 5.833

2.  Quality by design approach for green HPLC method development for simultaneous analysis of two thalassemia drugs in biological fluid with pharmacokinetic study.

Authors:  Michel Y Fares; Maha A Hegazy; Ghada M El-Sayed; Maha M Abdelrahman; Nada S Abdelwahab
Journal:  RSC Adv       Date:  2022-05-09       Impact factor: 4.036

Review 3.  Applications of scaffold-based advanced materials in biomedical sensing.

Authors:  Roya Sarkhosh-Inanlou; Vahid Shafiei-Irannejad; Sajjad Azizi; Abolghasem Jouyban; Jafar Ezzati-Nazhad Dolatabadi; Ahmad Mobed; Bashir Adel; Jafar Soleymani; Michael R Hamblin
Journal:  Trends Analyt Chem       Date:  2021-05-21       Impact factor: 14.908

4.  Spectrofluorimetric Method for Monitoring Methotrexate in Patients' Plasma Samples and Cell Lysates Using Highly Fluorescent Carbon Dots.

Authors:  Morteza Molaparast; Pooya Eslampour; Jafar Soleymani; Vahid Shafiei-Irannejad
Journal:  Iran J Pharm Res       Date:  2022-05-12       Impact factor: 1.962

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.